New Key Statistics Module, Z-Score and F-Score
NAS:FOLD Key Ratios
| Market Cap $ M | 2,976.80 |
| Enterprise Value $ M | 3,181.69 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 22.79 |
| Price/Sales | 7.08 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 423.00 |
| EPS (TTM) $ | -0.49 |
| Beneish M-Score | -2.6 |
| 10-y EBITDA Growth Rate % | 9.30 |
| 5-y EBITDA Growth Rate % | 26.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -35.46 |
| EV-to-EBITDA | -39.30 |
| PEG | -- |
| Shares Outstanding M | 296.20 |
| Net Margin (%) | -34.73 |
| Operating Margin % | -13.65 |
| Pre-tax Margin (%) | -33.17 |
| Quick Ratio | 2.61 |
| Current Ratio | 3.03 |
| ROA % (ttm) | -19.90 |
| ROE % (ttm) | -115.21 |
| ROIC % (ttm) | -18.08 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.62 |
FOLD Number of Guru Trades
FOLD Volume of Guru Trades
Gurus Latest Trades with NAS:FOLD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:FOLD is held by these investors
Total 1
Amicus Therapeutics Inc Insider Transactions
No Available Data
News about NAS:FOLD
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers